{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:25:01Z","timestamp":1791221101906,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jneuroim.2010.09.020","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T07:37:53Z","timestamp":1286955473000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Inflammation and gliosis in neurological diseases \u2013 clinical implications"],"prefix":"10.1016","volume":"231","author":[{"given":"Anna","family":"Cz\u0142onkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Kurkowska-Jastrz\u0119bska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.09.020_bb0005","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"Lyketsos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2010.04.022","article-title":"Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE","volume":"225","author":"Aharoni","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/156720508783884602","article-title":"Rofecoxib in patients with mild cognitive impairment: further analyses of data from a randomized, double-blind, trial","volume":"5","author":"Aisen","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.64.2.185","article-title":"Neuronal damage in brain inflammation","volume":"64","author":"Aktas","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrneurol.2010.76","article-title":"Fingolimod is a potential novel therapy for multiple sclerosis","volume":"6","author":"Aktas","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0035","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00004647-200012000-00007","article-title":"Role for matrix metalloproteinase after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94","volume":"20","author":"Asahi","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnet","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0045","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1096\/fj.01-0467fje","article-title":"Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity","volume":"16","author":"Barouch","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0050","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/mds.21552","article-title":"Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET","volume":"22","author":"Bartels","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0055","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1073\/pnas.0400569101","article-title":"Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"101","author":"Benner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00019052-200106000-00003","article-title":"Axonal and neuronal degeneration in multiple sclerosis: mechanism and functional consequences","volume":"14","author":"Bjartmar","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0065","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1212\/WNL.57.7.1248","article-title":"Axonal loss in normal appearing white matter in a patient with acute MS","volume":"57","author":"Bjartmar","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin 1 beta and interleukin 6 are elevated in cerebrospinal fluid of Alzheimer and de novo Parkinson' disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2005.03.005","article-title":"Activation of microglia by aggregated B-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-\u03b3 and IL-4 render them protective","volume":"29","author":"Butovsky","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2001.7735","article-title":"A clonal kine of mesencephalic progenitor cell converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease","volume":"171","author":"Carvey","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0085","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/039463200702000303","article-title":"Anti-chemokine therapy for inflammatory diseases","volume":"20","author":"Castellani","year":"2007","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0090","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0095","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease","volume":"58","author":"Chen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2003-1461","article-title":"Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease","volume":"63","author":"Ciesielska","year":"2003","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/135245859600100622","article-title":"Remyelination of the central nervous system","volume":"1","author":"Compston","year":"1996","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0110","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1460-9568.2005.04563.x","article-title":"Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis","volume":"23","author":"Danilov","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","article-title":"Microglial activation and its implications in the brain diseases","volume":"14","author":"Dheen","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.10253","article-title":"Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease","volume":"52","author":"Dodel","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jnnp.2004.054882","article-title":"Acute stroke investigators. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients","volume":"76","author":"Emsley","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J","article-title":"Quantitative pathological evidence for axonal loss in nrmal appearing white matter in multiple sclerosis","volume":"47","author":"Evangelou","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(01)00143-1","article-title":"Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis","volume":"14","author":"Fl\u00fcgel","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0140","doi-asserted-by":"crossref","first-page":"RC216","DOI":"10.1523\/JNEUROSCI.22-07-j0001.2002","article-title":"Neurodegenerative and neuroprotective effects of tumor necrosis factor in retinal ischemia: opposite roles of TNF receptor 1 and 2","volume":"22","author":"Fontaine","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0150","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1750-3639.2000.tb00268.x","article-title":"Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: involvement of microglial cells","volume":"10","author":"Gimsa","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia: biology and pathology","volume":"119","author":"Graeber","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/jnnp.2006.093104","article-title":"IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke","volume":"78","author":"Gromadzka","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0306-4522(91)90132-8","article-title":"Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal two-week-old rats in cultures","volume":"40","author":"Hama","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2006.11.019","article-title":"The role of helper cells in neuroprotection and regeneration","volume":"184","author":"Hendrix","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0180","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/01.wnl.0000204446.82823.28","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson's disease","volume":"66","author":"Hern\u00e1n","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompability complex class II positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cne.10119","article-title":"Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon","volume":"443","author":"Johansson","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2008.12.081","article-title":"Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"1261","author":"Joniec","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0200","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","article-title":"Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy","volume":"54","author":"Krady","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0205","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0210","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.intimp.2004.05.006","article-title":"Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease","volume":"4","author":"Kurkowska-Jastrzebska","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2004.10.027","article-title":"Immunization with myelin oligodendrocyte glycoprotein and complete Freund adjuvant partially protects dopaminergic neurons from 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced damage in mouse model of Parkinson's disease","volume":"131","author":"Kurkowska-Jastrzebska","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0220","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.intimp.2009.03.003","article-title":"Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease","volume":"9","author":"Kurkowska-Jastrzebska","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0225","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1567-5769(02)00078-4","article-title":"Indomethacin protects against neurodegeneration caused by MPTP intoxication in mouse","volume":"2","author":"Kurkowska-Jastrz\u0119bska","year":"2002","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0230","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ana.20860","article-title":"Ibuprofen and the mouse model of Parkinson's disease","volume":"59","author":"Kurkowska-Jastrz\u0119bska","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0235","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/WNR.0b013e3280586777","article-title":"Administration of anti-MBP T cells protects hippocampal neurons against trimethyltin-induced damage","volume":"5","author":"Kurkowska-Jastrz\u0119bska","year":"2007","journal-title":"NeuroReport"},{"issue":"suppl.2","key":"10.1016\/j.jneuroim.2010.09.020_bb0240","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/S1353-8020(08)70772-7","article-title":"Influence of anti-MOG CD4+ T cells on MPTP mediated injury of dopaminergic neurons in mice model of Parkinson's disease","volume":"13","author":"Kurkowska-Jastrz\u0119bska","year":"2007","journal-title":"Parkinsonism Rel. Dis."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0245","first-page":"233","article-title":"Anti-MBP T cells cause hippocampal neurons injury","volume":"203","author":"Kurkowska-Jastrz\u0119bska","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0250","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropiridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1471-4914(00)01909-2","article-title":"Heterogeneity of multiple sclerosis pathogenesis:implications for diagnosis and therapy","volume":"7","author":"Lassmann","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0260","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1191\/135248506ms1251oa","article-title":"Differential effect of Th1, monocyte\/macrophage and Th2 cytokines mixtures on early gene expression for immune related molecules in the central nervous system mixed glial cultures","volume":"12","author":"Lisak","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0270","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-4-30","article-title":"Differential effect of Th1, monocyte\/macrophage and Th2 cytokines mixtures on early gene expression for glial and neural-related molecules in the central nervous system mixed glial cultures: neurotrophins, growth factors and structural proteins","volume":"4","author":"Lisak","year":"2007","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0275","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Luchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0280","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-Dr in the substantia nigra in Parkinson's and Alzheimer's-disease brains","volume":"38","author":"Mac Geer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0285","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1747-4949.2008.00222.x","article-title":"Immune and inflammatory responses to stroke:good or bad?","volume":"3","author":"Mc Combe","year":"2008","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0290","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer's disease: epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0295","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/jaut.2000.0441","article-title":"Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity","volume":"15","author":"Moalem","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0300","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02252965","article-title":"Brain \u03b22-microglobulin levels are elevated in the striatum in Parkinson's disease","volume":"9","author":"Mogi","year":"1995","journal-title":"J. Neural Transm. [PD Sect]"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0305","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/WNL.0b013e3181e24373","article-title":"Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial","volume":"74","author":"Naismith","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0166-2236(00)02024-5","article-title":"Neuronal injury in bacterial meningitides mechanisms and implications for therapy","volume":"25","author":"Nau","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0315","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer's disease after immunization of amyloid \u03b2 peptide","volume":"9","author":"Nicole","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0320","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0325","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neuritis, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"issue":"suppl.1","key":"10.1016\/j.jneuroim.2010.09.020_bb0330","first-page":"S55","article-title":"Inflammation and Parkinson's disease pathogenesis","volume":"25","author":"Przedborski","year":"2010","journal-title":"Mov. Dis."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0335","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2004.05.095","article-title":"Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine administration to mouse","volume":"1019","author":"Przyby\u0142kowski","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0340","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","article-title":"Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration","volume":"25","author":"Purisai","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0345","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0350","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.neurobiolaging.2007.12.021","article-title":"18-month study of intravenous immunoglobulin for treatment of mild Alzheimer's disease","volume":"30","author":"Relkin","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/187152709787847315","article-title":"Antibody responses, amyloid-\u03b2 peptide remnants and clinical effects of AN-1792 immunization in patients with AD in an interrupted trial","volume":"8","author":"Roher","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0360","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/11316780-000000000-00000","article-title":"NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies","volume":"26","author":"Samii","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0365","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000113717","article-title":"Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases","volume":"5","author":"Sawada","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0370","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1007048903862","article-title":"Microglial motility in the rat facial nucleus following peripheral axotomy","volume":"28","author":"Schiefer","year":"1999","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0375","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.WCB.0000061881.75234.5E","article-title":"Macrophages and microglia in central nervous system injury: are they helpful or harmful?","volume":"23","author":"Schwartz","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0380","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2005.03.014","article-title":"Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases","volume":"233","author":"Schwartz","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0385","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tips.2008.03.006","article-title":"Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease?","volume":"29","author":"Schwartz","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0390","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2005.12.005","article-title":"Microglial phenotype: is the commitment reversible?","volume":"29","author":"Schwartz","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0395","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11481-005-9010-2","article-title":"Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy","volume":"1","author":"Schwartz","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0400","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/brain\/awq056","article-title":"Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology","volume":"133","author":"Serrano-Pozo","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0405","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0410","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1523\/JNEUROSCI.15-05-03468.1995","article-title":"Interleukin-1 attenuates excitatory amino acid induced neurodegeneration in vitro: involvement of nerve growth factor","volume":"15","author":"Strijbos","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0415","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental for Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0420","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ana.21845","article-title":"Degeneration versus autoimmunity in multiple sclerosis","volume":"66","author":"Tsutsui","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0425","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0169-328X(03)00179-7","article-title":"Association of interleukin-1 alpha gene polymorphism with cerebral infarction","volume":"115","author":"Um","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0430","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2010.01.006","article-title":"Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade","volume":"126","author":"Van der Walt","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0435","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2008.04.003","article-title":"Immunotherapy for neurological diseases","volume":"128","author":"Villoslada","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2006.07.014","article-title":"Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: role of microglia","volume":"50","author":"Wang","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0445","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1523\/JNEUROSCI.1090-04.2004","article-title":"Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition","volume":"24","author":"Wilcock","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(99)00212-X","article-title":"Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review","volume":"100","author":"Willenborg","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0455","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1160\/TH05-11-0772","article-title":"Endothelial dysfunction and systemic inflammation in persons with echolucent carotid plaques","volume":"96","author":"With Noto","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0460","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/01.STR.0000260099.42744.b0","article-title":"IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations","volume":"38","author":"Worrall","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jneuroim.2010.09.020_bb0465","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/glia.10172","article-title":"Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors","volume":"41","author":"Zhang","year":"2003","journal-title":"Glia"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281000439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281000439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:16:25Z","timestamp":1759047385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281000439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":93,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S016557281000439X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.09.020","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and gliosis in neurological diseases \u2013 clinical implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}